HOLLIE HOA NGUYEN GLENWRIGHT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SOMERDALE, NJ NPI 1700474665
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NJ Lilly USA, LLC All categories
General Payments — all program years on this page
$143.71
- Category: General Payments
- Program years: PY2021–2022
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $128.90 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $128.90 | 9 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $70.72 | 5 |
| Novo Nordisk AS | $29.83 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 1 |
| Acerta Pharma LLC | $14.06 | 1 |
By program year
Records — PY2022 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 887632661 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.29 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899182785 | Novo Nordisk Inc | $14.68 | 08/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899379873 | Novo Nordisk Inc | $15.15 | 05/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 914782175 | AstraZeneca Pharmaceuticals LP | $14.06 | 08/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918490245 | Lilly USA, LLC | $13.96 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918503289 | Lilly USA, LLC | $13.94 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918541541 | Lilly USA, LLC | $13.95 | 10/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918552783 | Lilly USA, LLC | $13.94 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 918572587 | Lilly USA, LLC | $14.93 | 04/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.